237 related articles for article (PubMed ID: 31077282)
1. Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus.
Cañez C; Selle K; Goh YJ; Barrangou R
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077282
[TBL] [Abstract][Full Text] [Related]
2. Characterization and comparison of CRISPR Loci in Streptococcus thermophilus.
Hu T; Cui Y; Qu X
Arch Microbiol; 2020 May; 202(4):695-710. PubMed ID: 31781808
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-based screening of genomic island excision events in bacteria.
Selle K; Klaenhammer TR; Barrangou R
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8076-81. PubMed ID: 26080436
[TBL] [Abstract][Full Text] [Related]
4. The endless battle between phages and CRISPR-Cas systems in
Philippe C; Moineau S
Biochem Cell Biol; 2021 Aug; 99(4):397-402. PubMed ID: 33534660
[TBL] [Abstract][Full Text] [Related]
5. Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.
Hynes AP; Lemay ML; Trudel L; Deveau H; Frenette M; Tremblay DM; Moineau S
Nat Protoc; 2017 Mar; 12(3):547-565. PubMed ID: 28207002
[TBL] [Abstract][Full Text] [Related]
6. Repurposing endogenous type II CRISPR-Cas9 system for genome editing in Streptococcus thermophilus.
Ma S; Wang F; Xuejing Z; Liping Q; Xueping G; Lu X; Qi Q
Biotechnol Bioeng; 2024 Feb; 121(2):749-756. PubMed ID: 37994543
[TBL] [Abstract][Full Text] [Related]
7. Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation.
Wei Y; Terns RM; Terns MP
Genes Dev; 2015 Feb; 29(4):356-61. PubMed ID: 25691466
[TBL] [Abstract][Full Text] [Related]
8. Genomic impact of CRISPR immunization against bacteriophages.
Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P
Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Cas proteins for CRISPR-Cas editing in streptomycetes.
Yeo WL; Heng E; Tan LL; Lim YW; Lim YH; Hoon S; Zhao H; Zhang MM; Wong FT
Biotechnol Bioeng; 2019 Sep; 116(9):2330-2338. PubMed ID: 31090220
[TBL] [Abstract][Full Text] [Related]
10. CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus.
Paez-Espino D; Sharon I; Morovic W; Stahl B; Thomas BC; Barrangou R; Banfield JF
mBio; 2015 Apr; 6(2):. PubMed ID: 25900652
[TBL] [Abstract][Full Text] [Related]
11. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
[TBL] [Abstract][Full Text] [Related]
12. CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR-Cas system.
Kim JG; Garrett S; Wei Y; Graveley BR; Terns MP
Nucleic Acids Res; 2019 Sep; 47(16):8632-8648. PubMed ID: 31392984
[TBL] [Abstract][Full Text] [Related]
13. The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus.
Carte J; Christopher RT; Smith JT; Olson S; Barrangou R; Moineau S; Glover CV; Graveley BR; Terns RM; Terns MP
Mol Microbiol; 2014 Jul; 93(1):98-112. PubMed ID: 24811454
[TBL] [Abstract][Full Text] [Related]
14. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
Heussler GE; O'Toole GA
J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
[TBL] [Abstract][Full Text] [Related]
15. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
Sapranauskas R; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
Nucleic Acids Res; 2011 Nov; 39(21):9275-82. PubMed ID: 21813460
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
Common J; Morley D; Westra ER; van Houte S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
[TBL] [Abstract][Full Text] [Related]
17. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
Garneau JE; Dupuis MÈ; Villion M; Romero DA; Barrangou R; Boyaval P; Fremaux C; Horvath P; Magadán AH; Moineau S
Nature; 2010 Nov; 468(7320):67-71. PubMed ID: 21048762
[TBL] [Abstract][Full Text] [Related]
18. A truncated anti-CRISPR protein prevents spacer acquisition but not interference.
Philippe C; Morency C; Plante PL; Zufferey E; Achigar R; Tremblay DM; Rousseau GM; Goulet A; Moineau S
Nat Commun; 2022 May; 13(1):2802. PubMed ID: 35589712
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the activity of abundant, diverse and active CRISPR-Cas systems in lactobacilli.
Crawley AB; Henriksen ED; Stout E; Brandt K; Barrangou R
Sci Rep; 2018 Aug; 8(1):11544. PubMed ID: 30068963
[TBL] [Abstract][Full Text] [Related]
20. Assembling the Streptococcus thermophilus clustered regularly interspaced short palindromic repeats (CRISPR) array for multiplex DNA targeting.
Guo L; Xu K; Liu Z; Zhang C; Xin Y; Zhang Z
Anal Biochem; 2015 Jun; 478():131-3. PubMed ID: 25748774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
